Travere Therapeutics drug approved for rare kidney disease - STAT

SAN DIEGO — Travere Therapeutics, a biotech focused both on treating rare diseases and distancing itself from controversial founder Martin Shkreli, on Friday won accelerated approval for a drug that treats IgA nephropathy, a rare and deadly autoimmune disease that attacks the kidneys and can lead…#san #martinshkreli #iga #filspari #phase3
Source: Reuters: Health - Category: Consumer Health News Source Type: news